Kalevi Kurkijarvi's most recent trade in FibroGen Inc was a trade of 7,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 26, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroGen Inc | Kalevi Kurkijarvi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 4,700 | 37,800 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 6,000 | 6,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.65 per share. | 17 Feb 2021 | 6,000 | 39,100 (0%) | 0% | 28.7 | 171,900 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Sale of securities on an exchange or to another person at price $ 52.31 per share. | 17 Feb 2021 | 5,156 | 33,944 (0%) | 0% | 52.3 | 269,710 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Sale of securities on an exchange or to another person at price $ 52.93 per share. | 17 Feb 2021 | 844 | 33,100 (0%) | 0% | 52.9 | 44,673 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.05 per share. | 19 Jan 2021 | 6,000 | 39,100 (0%) | 0% | 19.1 | 114,300 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Sale of securities on an exchange or to another person at price $ 43.38 per share. | 19 Jan 2021 | 6,000 | 33,100 (0%) | 0% | 43.4 | 260,280 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2021 | 5,999 | 6,000 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Sale of securities on an exchange or to another person at price $ 40.04 per share. | 14 Jan 2021 | 5,999 | 33,100 (0%) | 0% | 40.0 | 240,200 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.05 per share. | 14 Jan 2021 | 5,999 | 39,099 (0%) | 0% | 19.1 | 114,281 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.34 per share. | 28 Dec 2020 | 6,000 | 39,100 (0%) | 0% | 18.3 | 110,040 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Sale of securities on an exchange or to another person at price $ 40.39 per share. | 28 Dec 2020 | 5,901 | 33,200 (0%) | 0% | 40.4 | 238,341 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Sale of securities on an exchange or to another person at price $ 41.14 per share. | 28 Dec 2020 | 100 | 33,100 (0%) | 0% | 41.1 | 4,114 | Common Stock |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 1 | 11,999 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Kalevi Kurkijarvi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.00 per share. | 28 Dec 2020 | 1 | 39,101 (0%) | 0% | 19 | 19 | Common Stock |